flotsam,
Clinical trials are always a risk. But with the bits of data we have it looks extremely encouraging. Especially given the fact that they screened out those who looked to do well with the standard care - which is what we are compared against.
I think the ftt sp has been held back by the bad tis memories. But those people are gone and new investors won't care about that past.
flotsam, Clinical trials are always a risk. But with the bits of...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
